← Back

ALP Bio

Schlieren, Switzerland

seed$2.1M raisedDigital HealthBiotechDrug Discovery

Total Raised

$2.1M

Stage

seed

Location

Schlieren, Switzerland

Founded

2025

Team size

1-10

Links

About ALP Bio

Swiss biotech startup developing immune organoid and AI platform technology.

What sets it apart

It pairs human immune organoid readouts with AI models to provide human-relevant immunogenicity prediction and sequence redesign before clinical trials.

Sectors

Digital HealthBiotechDrug Discovery

Business

ModelSaaS

CustomerPharmaceutical and biotech companies developing therapeutic antibodies and other biologics

Notable

  • Raised CHF 150,000 from Venture Kick
  • Raised a €1.9 million pre-seed round in 2026
  • Built a platform centered on tonsil-derived immune organoids and generative AI

Funding rounds

seed$2.1M

30 Apr 2026

Source ↗

Explore the market

FAQ

What does ALP Bio do?

Swiss biotech startup developing immune organoid and AI platform technology.

Where is ALP Bio based?

ALP Bio is based in Schlieren, Switzerland, founded in 2025.

How much has ALP Bio raised?

ALP Bio has raised $2.1M in tracked funding and is currently at the seed stage.

Who has invested in ALP Bio?

Investors in ALP Bio include 42CAP and Venture Kick.